CCMH
IDXX icon

Cornerstone Capital Management Holdings’s Idexx Laboratories IDXX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.56M Buy
16,398
+1,263
+8% +$199K 0.02% 684
2017
Q3 		$2.35M Sell
15,135
-17,570
-54% -$2.78M 0.02% 681
2017
Q2 		$5.28M Sell
32,705
-6,852
-17% -$1.11M 0.04% 424
2017
Q1 		$6.12M Buy
39,557
+15,509
+64% +$2.14M 0.05% 416
2016
Q4 		$2.82M Sell
24,048
-45,591
-65% -$5.2M 0.02% 646
2016
Q3 		$7.85M Buy
69,639
+67,712
+3,514% +$7.14M 0.06% 352
2016
Q2 		$179K Buy
+1,927
New +$165K ﹤0.01% 1209

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Cornerstone Capital Management Holdings's IDXX Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Idexx Laboratories (IDXX) stake by 8.3% in Q4 2017, buying an estimated $199K and bringing the position to 16,398 shares worth $2.56M. The position accounts for 0.02% of the portfolio, ranked #684.

Cornerstone Capital Management Holdings first reported a position in IDXX in Q2 2016 and has held it in 7 quarters since. The position peaked at $7.85M in Q3 2016. 613 funds tracked by Wall St. Rank hold IDXX as of Q4 2017.

  • Cornerstone Capital Management Holdings held 16,398 shares of Idexx Laboratories worth $2.56M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 1,263 Idexx Laboratories shares in Q4 2017, an estimated $199K.
  • Idexx Laboratories made up 0.02% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #684 holding.
  • Cornerstone Capital Management Holdings first reported a position in Idexx Laboratories in Q2 2016 and has held it in 7 quarters since.
  • Cornerstone Capital Management Holdings's Idexx Laboratories position peaked at $7.85M in Q3 2016.
  • 613 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.